Integrated stress signaling pathways promote adaptive reprogramming for chondrocyte survival in Metaphyseal Chondrodysplasia Type Schmid

Abstract

Collagen X, encoded by the Col10a1 gene, is expressed specifically by hypertrophic chondrocytes (HCs) in the cartilage. Mutations of the Col10a1 gene in humans, which increase the endoplasmic reticulum (ER) stress in HCs, lead to metaphyseal chondrodysplasia type Schmid (MCDS). However, the mechanism of how HCs respond to ER stress to affect bone development and growth is not entirely understood. In this study, we generated a new mouse model harboring a 13 bp deletion (13del) in the endogenous Col10a1 gene. These 13del-MCDS mice display all the known clinical characteristics of human MCDS, as well as the molecular and cellular changes within the growth plate cartilage. For the first time, we found that triggering ER stress leads to activation of hypoxia and HIFs pathways in vivo, promoting cellular survival in HCs of the 13del-MCDS mice. To test whether the activated hypoxia and HIFs pathways are triggered by ER stress or extrinsic factors, we generated WT/GFP-MCDS chimera mice. Our findings showed that the activation of hypoxia and the hypoxic pathway is an intrinsic response to ER stress, which may partly occur through activation of ATF4 in HCs of mice. In parallel, p53 pathway changes and autophagy-associated protein-quality-control responses were observed in spatial association with altered chondrocyte differentiation and survival. These findings reveal coordinated engagement of multiple stress-response pathways during the adaptive response of hypertrophic chondrocytes to chronic ER stress.

References

[1] Richmond, C. M. & Savarirayan, R. Schmid Metaphyseal Chondrodysplasia. In GeneReviews® (eds Adam, M. P. et al.) (University of Washington, Seattle, 2019; updated 2024).

[2] Warman ML, et al. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat. Genet, 1993, 5: 79-82.

[3] Chan D, et al. A nonsense mutation in the carboxyl-terminal domain of type X collagen causes haploinsufficiency in schmid metaphyseal chondrodysplasia. J. Clin. Invest., 1998, 101: 1490-1499.

[4] Al Kaissi A, et al. Schmid’s type of metaphyseal chondrodysplasia: Diagnosis and management. Orthop. Surg., 2018, 10: 241-246.

[5] Kronenberg HM. Developmental regulation of the growth plate. Nature, 2003, 423: 332-336.

[6] Bateman JF, Shoulders MD, Lamande SR. Collagen misfolding mutations: the contribution of the unfolded protein response to the molecular pathology. Connect Tissue Res, 2022, 63: 210-227.

[7] Bateman JF, et al. Mutations of COL10A1 in Schmid metaphyseal chondrodysplasia. Hum. Mutat., 2005, 25: 525-534.

[8] Bateman JF, et al. Identification of four novel COL10A1 missense mutations in schmid metaphyseal chondrodysplasia: further evidence that collagen X NC1 mutations impair trimer assembly. Hum. Mutat., 2004, 23: 396.

[9] Ikegawa S, et al. Mutations in the N-terminal globular domain of the type X collagen gene (COL10A1) in patients with Schmid metaphyseal chondrodysplasia. Hum. Mutat., 1997, 9: 131-135.

[10] Makitie O, et al. Schmid type of metaphyseal chondrodysplasia and COL10A1 mutations-findings in 10 patients. Am. J. Med Genet. A, 2005, 137A: 241-248.

[11] Marks DS, et al. Metaphyseal chondrodysplasia type Schmid mutations are predicted to occur in two distinct three-dimensional clusters within type X collagen NC1 domains that retain the ability to trimerize. J. Biol. Chem., 1999, 274: 3632-3641.

[12] Chan D, et al. Site-directed mutagenesis of human type X collagen. Expression of alpha1(X) NC1, NC2, and helical mutations in vitro and in transfected cells. J. Biol. Chem., 1996, 271: 13566-13572.

[13] Chan D, et al. Interaction of collagen alpha1(X) containing engineered NC1 mutations with normal alpha1(X) in vitro. Implications for the molecular basis of schmid metaphyseal chondrodysplasia. J. Biol. Chem., 1999, 274: 13091-13097.

[14] Tsang KY, et al. Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol., 2007, 5: e44.

[15] Ho MS, et al. COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type Schmid. Hum. Mol. Genet, 2007, 16: 1201-1215.

[16] Walter P, Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science, 2011, 334: 1081-1086.

[17] Hotamisligil GS, Davis RJ. Cell signaling and stress responses. Cold Spring Harb. Perspect. Biol., 2016, 8: a006072.

[18] Horiuchi K, Tohmonda T, Morioka H. The unfolded protein response in skeletal development and homeostasis. Cell Mol. Life Sci., 2016, 73: 2851-2869.

[19] Rajpar MH, et al. Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLoS Genet, 2009, 5: e1000691.

[20] Wang C, et al. Inhibiting the integrated stress response pathway prevents aberrant chondrocyte differentiation thereby alleviating chondrodysplasia. Elife, 2018, 7: e37673.

[21] Chan WCW, et al. Activating the unfolded protein response in osteocytes causes hyperostosis consistent with craniodiaphyseal dysplasia. Hum. Mol. Genet, 2017, 26: 4572-4587.

[22] Mullan LA, et al. Increased intracellular proteolysis reduces disease severity in an ER stress-associated dwarfism. J. Clin. Invest., 2017, 127: 3861-3865.

[23] Forouhan M, Sonntag S, Boot-Handford RP. Carbamazepine reduces disease severity in a mouse model of metaphyseal chondrodysplasia type Schmid caused by a premature stop codon (Y632X) in the Col10a1 gene. Hum. Mol. Genet., 2018, 27: 3840-3853.

[24] Elliott AM, et al. Hand involvement in Schmid metaphyseal chondrodysplasia. Am. J. Med. Genet. A, 2005, 132A: 191-193.

[25] Lachman RS, Rimoin DL, Spranger J. Metaphyseal chondrodysplasia, Schmid type. Clinical and radiographic delineation with a review of the literature. Pediatr. Radio., 1988, 18: 93-102.

[26] Wasylenko MJ, Wedge JH, Houston CS. Metaphyseal chondrodysplasia, Schmid type. A defect of ultrastructural metabolism: case report. J. Bone Jt. Surg. Am., 1980, 62: 660-663.

[27] Baric I, et al. A 17-month-old boy with bowed legs. Eur. J. Pediatr., 2000, 159: 863-865.

[28] Zhang P, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature, 1997, 387: 151-158.

[29] Hatada I, Mukai T. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat. Genet., 1995, 11: 204-206.

[30] Yao Q, et al. Suppressing mitochondrial respiration is critical for hypoxia tolerance in the fetal growth plate. Dev. Cell, 2019, 49: 748-763 e7.

[31] Simon MC, Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell Biol., 2008, 9: 285-296.

[32] Rosati R, et al. Normal long bone growth and development in type X collagen-null mice. Nat. Genet., 1994, 8: 129-135.

[33] Kwan KM, et al. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: Implications for function. J. Cell Biol., 1997, 136: 459-471.

[34] Petitjean A, et al. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis, 2008, 29: 273-281.

[35] Sullivan A, Lu X. ASPP: A new family of oncogenes and tumour suppressor genes. Br. J. Cancer, 2007, 96: 196-200.

[36] Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J. Biochem Cell Biol., 2004, 36: 2503-2518.

[37] Kung LH, et al. Hypertrophic chondrocytes have a limited capacity to cope with increases in endoplasmic reticulum stress without triggering the unfolded protein response. J. Histochem Cytochem, 2012, 60: 734-748.

[38] Welihinda AA, Tirasophon W, Kaufman RJ. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Expr., 1999, 7: 293-300

[39] Szegezdi E, et al. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep., 2006, 7: 880-885.

[40] Cameron TL, et al. Transcriptional profiling of chondrodysplasia growth plate cartilage reveals adaptive ER-stress networks that allow survival but disrupt hypertrophy. PLoS One, 2011, 6: e24600.

[41] Kurosu H, Kuro OM. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol. Cell Endocrinol., 2009, 299: 72-78.

[42] Flippo KH, Potthoff MJ. Metabolic messengers: FGF21. Nat. Metab., 2021, 3: 309-317.

[43] Kudelko M, et al. Label-free quantitative proteomics reveals survival mechanisms developed by hypertrophic chondrocytes under ER stress. J. Proteome Res, 2016, 15: 86-99.

[44] Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer, 2008, 8: 851-864.

[45] Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat. Rev. Mol. Cell Biol., 2020, 21: 268-283.

[46] Bi M, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J., 2005, 24: 3470-3481.

[47] Tyo KE, et al. Imbalance of heterologous protein folding and disulfide bond formation rates yields runaway oxidative stress. BMC Biol., 2012, 10. 16

[48] Bravo R, et al. Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J. Cell Sci., 2011, 124: 2143-2152.

[49] St-Pierre J, et al. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem., 2002, 277: 44784-44790.

[50] Balsa E, et al. ER and nutrient stress promote assembly of respiratory chain supercomplexes through the PERK-eIF2alpha axis. Mol. Cell, 2019, 74: 877-890.e6.

[51] Cao SS, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal, 2014, 21: 396-413.

[52] Le HT, et al. eIF2alpha phosphorylation-ATF4 axis-mediated transcriptional reprogramming mitigates mitochondrial impairment during ER stress. Mol. Cells, 2025, 48: 100176.

[53] Chee NT, et al. Activating transcription factor 4 regulates hypoxia inducible factor 1alpha in chronic hypoxia in pancreatic cancer cells. Oncol. Rep., 2023, 49: 14.

[54] Ye J, Koumenis C. ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis. Curr. Mol. Med, 2009, 9: 411-416.

[55] Zhu K, et al. ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment. J. Bone Miner. Res, 2013, 28: 1870-1884.

[56] Schipani E, et al. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev., 2001, 15: 2865-2876.

[57] Qu L, et al. Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3beta. Genes Dev., 2004, 18: 261-277.

[58] Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell, 2009, 137: 413-431.

[59] Koumenis C, et al. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell Biol., 2001, 21: 1297-1310.

[60] Sermeus A, Michiels C. Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis., 2011, 2. e164

[61] White E. Autophagy and p53. Cold Spring Harb. Perspect. Med, 2016, 6: a026120.

[62] Crighton D, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell, 2006, 126: 121-134.

[63] Vigano MA, Mantovani R. Hitting the numbers: the emerging network of p63 targets. Cell Cycle, 2007, 6: 233-239.

[64] Yang A, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 1998, 2: 305-316.

[65] Xiao, Y., et al., ASPP2 Is Phosphorylated by CDK1 during mitosis and required for pancreatic cancer cell proliferation. Cancers (Basel)15, 5424 (2023).

[66] Bergamaschi D, et al. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat. Genet, 2006, 38: 1133-1141.

[67] Bergamaschi D, et al. ASPP1 and ASPP2: common activators of p53 family members. Mol. Cell Biol., 2004, 24: 1341-1350.

[68] Borges KS, Arboleda VA, Vilain E. Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase. Cell Div., 2015, 10. 2

[69] Vlachos P, et al. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway. Cell Death Differ., 2007, 14: 1497-1507.

[70] Costa-Mattioli, M. & Walter P., The integrated stress response: From mechanism to disease. Science368 (2020).

[71] Pakos-Zebrucka K, et al. The integrated stress response. EMBO Rep., 2016, 17: 1374-1395.

[72] Rzymski T, et al. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene, 2010, 29: 4424-4435.

[73] Rodriguez CI, et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-lox. Nat. Genet, 2000, 25: 139-140.

[74] Novak A, et al. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis, 2000, 28: 147-155.

[75] Cheah KS, et al. Human COL2A1-directed SV40 T antigen expression in transgenic and chimeric mice results in abnormal skeletal development. J. Cell Biol., 1995, 128: 223-237.

[76] Kodama Y, et al. Cortical tibial bone volume in two strains of mice: effects of sciatic neurectomy and genetic regulation of bone response to mechanical loading. Bone, 1999, 25: 183-190.

[77] Hasegawa T, et al. Japanese type of spondylo-metaphyseal dysplasia. Pediatr. Radiol., 1994, 24: 194-197.

[78] Kobayashi T, et al. PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development, 2002, 129: 2977-2986.

[79] Chung UI, et al. Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J. Clin. Invest., 2001, 107: 295-304.

[80] Inada M, et al. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. USA, 2004, 101: 17192-17197.

Funding

Research Grants Council, University Grants Committee (RGC, UGC)(AoE 04/04;HKU 706608;T-12-708/12N)

Rights & permissions

The Author(s)